UK Government Prepares for Potential Brexit Disruption of Coronavirus Vaccines

Strategic Insights -

The UK Government is working on contingency plans to ensure the smooth supply of coronavirus vaccines, including the potential for flying in vaccines from Europe to avoid potential disruptions at the border when the UK leaves the single market and customs union on January 1. Health Secretary Matt Hancock has expressed confidence that a no-deal Brexit will not delay vaccine supplies, but warned that the Government has a plan in place for all eventualities, including flying in vaccines if necessary. Meanwhile, the head of British firm Croda International, which supplies a crucial ingredient in the Pfizer-BioNTech vaccine candidate, has warned that avoiding border disruption will be "a crucial step" in ensuring the vaccine is available to millions of people.

Key Takeaways:

  • The UK Government is working on contingency plans to ensure the smooth supply of coronavirus vaccines, including flying in vaccines from Europe if necessary.
  • Health Secretary Matt Hancock has expressed confidence that a no-deal Brexit will not delay vaccine supplies, but warned that the Government has a plan in place for all eventualities.
  • The Government has invested hundreds of millions of pounds in border infrastructure and customs clearances to minimize disruption.
  • Business Secretary Alok Sharma has warned that even with a post-Brexit trade deal, there will still be major changes to cross-border trade.
  • The Government is communicating with businesses to ensure they are ready for the end of the transition period and are aware of individual areas where they will need to adapt.
  • Croda International's CEO, Steve Foots, has warned that the end of the Brexit transition poses a risk for the vaccine supply chain.

Statistics:

  • The UK Government has invested £hundreds of millions of pounds in border infrastructure.
  • The Government has been writing to hundreds of thousands of businesses on a weekly basis to prepare them for the end of the transition period.
  • The end of the Brexit transition poses risks for the vaccine supply chain, with potential delays due to customs clearances and border friction.

Sources:

  • BBC Question Time, Health Secretary Matt Hancock
  • Sky News, Croda International's CEO, Steve Foots
  • Downing Street press conference, Business Secretary Alok Sharma